SanBio, Inc.
Biotechnology ResearchCalifornia, United States11-50 Employees
SanBio, Inc. is a small biotechnology company based in Mountain View, California, founded in 2001. It develops, manufactures, and markets regenerative cell medicines aimed at treating disabilities caused by central nervous system diseases, with an emphasis on addressing underlying disease mechanisms rather than just symptoms. As of 2016, the company had advanced SB623—its regenerative cell therapy for central nervous system disorders—into clinical development for chronic motor impairment from ischemic stroke and traumatic brain injury in Japan and the United States. SanBio positions itself in the regenerative medicine field, pursuing global leadership through continued development and strategic partnerships and licenses. It has engaged in manufacturing and development collaborations, including a 2018 alliance with Hitachi Chemical related to SB623 production, and has expanded its intellectual property through the acquisition of a patent portfolio focused on cell medicines derived from mesenchymal stem cells. The company emphasizes pursuing indications and geographic expansion by combining internal development with external collaborations.
1-888-653-2347 
support@leadiq.com 
